“Special Treatment”: BiDil, Tuskegee, and the Logic of Race

Journal of Law, Medicine and Ethics 36 (3):478-484 (2008)
  Copy   BIBTEX

Abstract

BiDil, a drug approved in 2005 by the FDA only for African Americans, was seen by many as almost reparations for the horrors of the Tuskegee Syphilis Study where treatment for black men was denied. The logic of race, however, rather than racism, links BiDil to the past many thought it was escaping

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 91,475

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

Similar books and articles

Race, Pharmacogenomics, and Marketing: Putting BiDil in Context.Jonathan Kahn - 2006 - American Journal of Bioethics 6 (5):W1-W5.
Popular Representations of Race: The News Coverage of BiDil.Timothy Caulfield & Simrat Harry - 2008 - Journal of Law, Medicine and Ethics 36 (3):485-490.
The Logic of Special Rights.Paul Green - 1987 - Hypatia 2 (1):67 - 70.
Race, Social Identity, Human Dignity.Jan Narveson - 2000 - Social Philosophy Today 16:159-170.
Race and Racism in Modern Philosophy.Andrew Valls (ed.) - 2005 - Cornell University Press.
Race Concepts in Medicine.M. O. Hardimon - 2013 - Journal of Medicine and Philosophy 38 (1):6-31.

Analytics

Added to PP
2010-09-13

Downloads
25 (#627,007)

6 months
1 (#1,479,630)

Historical graph of downloads
How can I increase my downloads?

Citations of this work

Add more citations

References found in this work

Inclusion: The Politics of Difference in Medical Research.Steven Epstein - 2008 - International Journal of Feminist Approaches to Bioethics 1 (2):174-178.

Add more references